Combined intensive therapies at home in spastic unilateral cerebral palsy with high bimanual functional performance. What do they offer? A comparative randomised clinical trial

Background: Children with unilateral spastic cerebral palsy (USCP) receive different treatments, including the application of modified constraint induced movement therapy (mCIMT) or bimanual intensive therapy (BIT) to increase affected upper limb functionality. The aim of this study was to compare t...

Full description

Bibliographic Details
Main Authors: Rocío Palomo-Carrión, Cristina Lirio-Romero, Asunción Ferri-Morales, Patricia Jovellar-Isiegas, María-Dolores Cortés-Vega, Helena Romay-Barrero
Format: Article
Language:English
Published: SAGE Publishing 2021-08-01
Series:Therapeutic Advances in Chronic Disease
Online Access:https://doi.org/10.1177/20406223211034996
id doaj-f9b20ba864d24986814ed69ecf0c10d5
record_format Article
spelling doaj-f9b20ba864d24986814ed69ecf0c10d52021-08-13T02:33:51ZengSAGE PublishingTherapeutic Advances in Chronic Disease2040-62312021-08-011210.1177/20406223211034996Combined intensive therapies at home in spastic unilateral cerebral palsy with high bimanual functional performance. What do they offer? A comparative randomised clinical trialRocío Palomo-CarriónCristina Lirio-RomeroAsunción Ferri-MoralesPatricia Jovellar-IsiegasMaría-Dolores Cortés-VegaHelena Romay-BarreroBackground: Children with unilateral spastic cerebral palsy (USCP) receive different treatments, including the application of modified constraint induced movement therapy (mCIMT) or bimanual intensive therapy (BIT) to increase affected upper limb functionality. The aim of this study was to compare the effectiveness of two protocols with different proportions and orders of mCIMT/BIT within combined intensive home-therapy in children with USCP (6–8 years old) with high bimanual functional performance, applied by the family. Methods: The protocols were performed on 20 children with an average age of 7.12 years [standard deviation (SD): 0.70], allocated to two different combined therapies. The protocols were designed by 100 h of dose for 10 weeks: 80 h of mCIMT followed by 20 h of BIT (mCIMT-B group) and 80 h of BIT followed by 20 h of mCIMT (BIT-mCI group). Bimanual functional performance was measured with Assisting Hand Assessment Scale (AHA) and the affected upper limb-use experience with Children’s Hand-use Experience Questionnaire (CHEQ). Parent satisfaction and expectations with therapy were measured using a specific questionnaire. There were five assessment timepoints (week 0, week 4, week 8, week 10 and week 34). Results: There were no statistically significant ( p  > 0.05) inter- and intra-group changes in the bimanual functional performance of both groups. The affected upper limb-use experience obtained significant changes in BIT-mCI group, with statistically significant differences in the pairwise comparisons between week 0–10 and week 4–10 ( p  = 0.028) for use of the affected hand and the use of the affected hand to grasp between week 4 and week 8 ( p  = 0.028). Grasp efficacy and discomfort acquired statistically significant differences only in the BIT-mCI group for pairwise comparisons week 0–week 10/week 4–week 10 ( p  = 0.035). Although task execution time compared with a typically developing child of the same age obtained statistically significant differences only in the group mCIMT-B for pairwise comparisons week 0–week 8 ( p  = 0.03), week 0–week 10 ( p  = 0.03), week 4–week 8 ( p  = 0.04) and week 4–week 10 ( p  = 0.03). Family satisfaction and expectations acquired an increase between week 0 and week 10 ( p  ⩽ 0.02). Conclusion: Applying 80 h of BIT for 8 weeks in children with high bimanual functional performance USCP (6–8 years old), executed at home with family involvement would be sufficient to obtain improvements in affected upper limb-use experience, without the need to use combined protocols of 100 h. However, no statistically significant increase in bimanual functional performance would be obtained, with the basal situation of the child being a factor to consider for the execution of mCIMT and BIT. Registration number and name of trial registry: [ClinicalTrials.gov identifier: NCT03465046]https://doi.org/10.1177/20406223211034996
collection DOAJ
language English
format Article
sources DOAJ
author Rocío Palomo-Carrión
Cristina Lirio-Romero
Asunción Ferri-Morales
Patricia Jovellar-Isiegas
María-Dolores Cortés-Vega
Helena Romay-Barrero
spellingShingle Rocío Palomo-Carrión
Cristina Lirio-Romero
Asunción Ferri-Morales
Patricia Jovellar-Isiegas
María-Dolores Cortés-Vega
Helena Romay-Barrero
Combined intensive therapies at home in spastic unilateral cerebral palsy with high bimanual functional performance. What do they offer? A comparative randomised clinical trial
Therapeutic Advances in Chronic Disease
author_facet Rocío Palomo-Carrión
Cristina Lirio-Romero
Asunción Ferri-Morales
Patricia Jovellar-Isiegas
María-Dolores Cortés-Vega
Helena Romay-Barrero
author_sort Rocío Palomo-Carrión
title Combined intensive therapies at home in spastic unilateral cerebral palsy with high bimanual functional performance. What do they offer? A comparative randomised clinical trial
title_short Combined intensive therapies at home in spastic unilateral cerebral palsy with high bimanual functional performance. What do they offer? A comparative randomised clinical trial
title_full Combined intensive therapies at home in spastic unilateral cerebral palsy with high bimanual functional performance. What do they offer? A comparative randomised clinical trial
title_fullStr Combined intensive therapies at home in spastic unilateral cerebral palsy with high bimanual functional performance. What do they offer? A comparative randomised clinical trial
title_full_unstemmed Combined intensive therapies at home in spastic unilateral cerebral palsy with high bimanual functional performance. What do they offer? A comparative randomised clinical trial
title_sort combined intensive therapies at home in spastic unilateral cerebral palsy with high bimanual functional performance. what do they offer? a comparative randomised clinical trial
publisher SAGE Publishing
series Therapeutic Advances in Chronic Disease
issn 2040-6231
publishDate 2021-08-01
description Background: Children with unilateral spastic cerebral palsy (USCP) receive different treatments, including the application of modified constraint induced movement therapy (mCIMT) or bimanual intensive therapy (BIT) to increase affected upper limb functionality. The aim of this study was to compare the effectiveness of two protocols with different proportions and orders of mCIMT/BIT within combined intensive home-therapy in children with USCP (6–8 years old) with high bimanual functional performance, applied by the family. Methods: The protocols were performed on 20 children with an average age of 7.12 years [standard deviation (SD): 0.70], allocated to two different combined therapies. The protocols were designed by 100 h of dose for 10 weeks: 80 h of mCIMT followed by 20 h of BIT (mCIMT-B group) and 80 h of BIT followed by 20 h of mCIMT (BIT-mCI group). Bimanual functional performance was measured with Assisting Hand Assessment Scale (AHA) and the affected upper limb-use experience with Children’s Hand-use Experience Questionnaire (CHEQ). Parent satisfaction and expectations with therapy were measured using a specific questionnaire. There were five assessment timepoints (week 0, week 4, week 8, week 10 and week 34). Results: There were no statistically significant ( p  > 0.05) inter- and intra-group changes in the bimanual functional performance of both groups. The affected upper limb-use experience obtained significant changes in BIT-mCI group, with statistically significant differences in the pairwise comparisons between week 0–10 and week 4–10 ( p  = 0.028) for use of the affected hand and the use of the affected hand to grasp between week 4 and week 8 ( p  = 0.028). Grasp efficacy and discomfort acquired statistically significant differences only in the BIT-mCI group for pairwise comparisons week 0–week 10/week 4–week 10 ( p  = 0.035). Although task execution time compared with a typically developing child of the same age obtained statistically significant differences only in the group mCIMT-B for pairwise comparisons week 0–week 8 ( p  = 0.03), week 0–week 10 ( p  = 0.03), week 4–week 8 ( p  = 0.04) and week 4–week 10 ( p  = 0.03). Family satisfaction and expectations acquired an increase between week 0 and week 10 ( p  ⩽ 0.02). Conclusion: Applying 80 h of BIT for 8 weeks in children with high bimanual functional performance USCP (6–8 years old), executed at home with family involvement would be sufficient to obtain improvements in affected upper limb-use experience, without the need to use combined protocols of 100 h. However, no statistically significant increase in bimanual functional performance would be obtained, with the basal situation of the child being a factor to consider for the execution of mCIMT and BIT. Registration number and name of trial registry: [ClinicalTrials.gov identifier: NCT03465046]
url https://doi.org/10.1177/20406223211034996
work_keys_str_mv AT rociopalomocarrion combinedintensivetherapiesathomeinspasticunilateralcerebralpalsywithhighbimanualfunctionalperformancewhatdotheyofferacomparativerandomisedclinicaltrial
AT cristinalirioromero combinedintensivetherapiesathomeinspasticunilateralcerebralpalsywithhighbimanualfunctionalperformancewhatdotheyofferacomparativerandomisedclinicaltrial
AT asuncionferrimorales combinedintensivetherapiesathomeinspasticunilateralcerebralpalsywithhighbimanualfunctionalperformancewhatdotheyofferacomparativerandomisedclinicaltrial
AT patriciajovellarisiegas combinedintensivetherapiesathomeinspasticunilateralcerebralpalsywithhighbimanualfunctionalperformancewhatdotheyofferacomparativerandomisedclinicaltrial
AT mariadolorescortesvega combinedintensivetherapiesathomeinspasticunilateralcerebralpalsywithhighbimanualfunctionalperformancewhatdotheyofferacomparativerandomisedclinicaltrial
AT helenaromaybarrero combinedintensivetherapiesathomeinspasticunilateralcerebralpalsywithhighbimanualfunctionalperformancewhatdotheyofferacomparativerandomisedclinicaltrial
_version_ 1721209248731365376